Drugs
-
Approvals - November 2001
| ANDA Number | Drug Name | Applicant | Approval Date | |
|---|---|---|---|---|
| 1 | 75-916 | RIMANTADINE HYDROCHLORIDE TABLETS 100 MG | COREPHARMA LLC | 11/2/01 |
| 2 | 75-682 | IBUPROFEN TABLETS, USP 400 MG, 600 MG, AND 800 MG | BASF CORPORATION | 11/14/01 |
| 3 | 75-347 | OMEPRAZOLE DELAYED-RELEASE CAPSULES 10 MG, 20 MG, AND 40 MG | ANDRX PHARMACEUTICALS, INC. | 11/16/01 |
| 4 | 65-034 | DAUNORUBICIN HYDROCHLORIDE INJECTION 5 MG (BASE)/ML; 4 ML SINGLE-DOSE VIALS | SUPERGEN, INC. | 11/20/01 |
| 5 | 76-117 | IBUPROFEN TABLETS, USP (OTC) 200 MG | DR. REDDY'S LABORATORIES LIMITED | 11/20/01 |
| 6 | 75-569 | THALLOUS CHLORIDE TL-201 INJECTION, USP 1 mCi/ML | MOUNT SINAI MEDICAL CENTER | 11/21/01 |
| 7 | 75-749 | DILTIAZEM HYDROCHLORIDE INJECTION 5 MG/ML, PACKAGED IN 25 MG/5 ML SYRINGE AND 50 MG/10 ML DILUTE-A-JET SYRINGE | INTERNATIONAL MEDICATION SYSTEMS LIMITED | 11/21/01 |
| 8 | 75-915 | TIOCONAZOLE VAGINAL OINTMENT 6.5% (OTC) | L. PERRIGO COMPANY | 11/21/01 |
| 9 | 40-434 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN TABLETS, USP 7.5 MG/325 MG, AND 10 MG/325 MG | ENDO PHARMACEUTICALS, INC. | 11/23/01 |
| 10 | 75-870 | FAMOTIDINE INJECTION (PRESERVATIVE-FREE) 10 MG/ML (20 MG/2 ML SINGLE-DOSE VIAL) | ABBOTT LABORATORIES | 11/23/01 |
| 11 | 75-905 | FAMOTIDINE INJECTION 10 MG/ML; PACKAGED IN 4 ML & 20 ML MULTIPLE-DOSE VIALS | ABBOTT LABORATORIES | 11/23/01 |
| 12 | 75-794 | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE TABLETS, USP 250 MG/250 MG/65 MG, RESPECTIVELY (OTC) | L. PERRIGO COMPANY | 11/26/01 |
| 13 | 76-057 | ETHAMBUTOL HYDROCHLORIDE TABLETS, USP 400 MG | BARR LABORATORIES, INC. | 11/26/01 |
| 14 | 75-404 | FAMOTIDINE TABLETS, USP (OTC) 10 MG | DANBURY PHARMACAL, INC. | 11/28/01 |
| 15 | 75-721 | LEUPROLIDE ACETATE INJECTION 1 MG/0.2 ML (2.8 ML MULTIPLE-DOSE VIALS) | GENZYME CORPORATION | 11/29/01 |
| 16 | 75-998 | PROPAFENONE HYDROCHLORIDE TABLETS 150 MG, 225 MG, AND 300 MG | MUTUAL PHARMACEUTICAL COMPANY | 11/29/01 |
| 17 | 75-231 | BUTALBITAL, ASPIRIN, CAFFEINE, & CODEINE PHOSPHATE CAPS, USP 50 MG/325 MG/40 MG/30 MG | ANABOLIC, INC. | 11/30/01 |
| 18 | 75-829 | ETODOLAC EXTENDED-RELEASE TABLETS 400 MG 500 MG | ANDRX PHARMACEUTICALS, L.L.C. | 11/30/01 |
| 19 | 75-840 | NORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP 21-DAY & 28-DAY REGIMENS; 0.3 MG/0.03 MG NOTE:28-DAY REGIMEN ALSO CONTAINS 7 INERT TABLETS. | DURAMED PHARMACEUTICALS, INC. | 11/30/01 |
-
-







